1-7 of 7
Therapeutics & Molecular Medicine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

The role of thalamic group II mGlu receptors in health and disease

In Collection
Celebrating 125 years of the Synapse
Caroline S. Copeland, Thomas E. Salt
Journal: Neuronal Signaling
Neuronal Signal (2022) 6 (4): NS20210058.
DOI: https://doi.org/10.1042/NS20210058
Published: 15 November 2022
View article titled, The role of thalamic group II mGlu receptors in health and disease
Click here to open pdf in another window PDF for The role of thalamic group II mGlu receptors in health and disease
Articles

Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease

Louis Dwomoh, Gonzalo S. Tejeda, Andrew B. Tobin
Journal: Neuronal Signaling
Neuronal Signal (2022) 6 (1): NS20210004.
DOI: https://doi.org/10.1042/NS20210004
Published: 21 April 2022
View article titled, Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
Click here to open pdf in another window PDF for Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
Articles

Cannabidiol modulation of oxidative stress and signalling

Sónia R. Pereira, Becky Hackett, David N. O’Driscoll, Melody Cui Sun, Eric J. Downer
Journal: Neuronal Signaling
Neuronal Signal (2021) 5 (3): NS20200080.
DOI: https://doi.org/10.1042/NS20200080
Published: 24 August 2021
View article titled, Cannabidiol modulation of oxidative stress and signalling
Click here to open pdf in another window PDF for Cannabidiol modulation of oxidative stress and signalling
Articles

5-HT 2A receptor loss does not alter acute fluoxetine-induced anxiety and exhibit sex-dependent regulation of cortical immediate early gene expression

Minal Jaggar, Toshali Banerjee, Noelia Weisstaub, Jay A. Gingrich, Vidita A. Vaidya
Journal: Neuronal Signaling
Neuronal Signal (2019) 3 (1): NS20180205.
DOI: https://doi.org/10.1042/NS20180205
Published: 01 February 2019
View article titled, 5-HT 2A receptor loss does not alter acute fluoxetine-induced anxiety and exhibit sex-dependent regulation of cortical immediate early gene expression
Click here to open pdf in another window PDF for 5-HT 2A receptor loss does not alter acute fluoxetine-induced anxiety and exhibit sex-dependent regulation of cortical immediate early gene expression
Includes: Supplementary data
Articles

Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options

J. Daniel Lafreniere, Melanie E.M. Kelly
Journal: Neuronal Signaling
Neuronal Signal (2018) 2 (4): NS20170144.
DOI: https://doi.org/10.1042/NS20170144
Published: 02 November 2018
View article titled, Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options
Click here to open pdf in another window PDF for Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options
Articles

Therapeutic use of botulinum toxin in pain treatment

Raj Kumar
Journal: Neuronal Signaling
Neuronal Signal (2018) 2 (3): NS20180058.
DOI: https://doi.org/10.1042/NS20180058
Published: 31 August 2018
View article titled, Therapeutic use of botulinum toxin in pain treatment
Click here to open pdf in another window PDF for Therapeutic use of botulinum toxin in pain treatment
Articles

Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?

Sarah J. Bailey, Stephen M. Husbands
Journal: Neuronal Signaling
Neuronal Signal (2018) 2 (2): NS20170145.
DOI: https://doi.org/10.1042/NS20170145
Published: 14 May 2018
View article titled, Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?
Click here to open pdf in another window PDF for Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?